Pharmacokinetics and pharmacodynamics in antibiotic dose optimization

Area of Science:

• Pharmacology
• Microbiology
• Drug Development

Background:

• Optimized antibiotic dosing is critical to prevent drug resistance.
• Suboptimal regimens and drug choice contribute to resistant bacteria, limiting treatment options.
• Novel strategies are needed to accelerate antimicrobial development.

Purpose of the Study:

• To review modeling and simulation approaches for optimizing antimicrobial pharmacokinetics and pharmacodynamics (PK-PD).
• To discuss methods for evaluating antimicrobial efficacy and guiding dosing strategies.
• To highlight the importance of PK-PD integration in preclinical and clinical development.

Main Methods:

• Examination of PK-PD of antimicrobial agents using modeling and simulation.
• Utilizing minimum inhibitory concentration (MIC) and time-kill kinetic studies.
• Discussing empirical, semi-mechanistic, and mechanistic models of bacterial dynamics and resistance.

Main Results:

• Modeling approaches provide insights into bacterial response to dosing regimens.
• Animal studies can evaluate efficacy by mimicking human pharmacokinetics.
• PK-PD models aid in understanding bacterial dynamics and resistance development.

Conclusions:

• PK-PD modeling streamlines drug development and aids decision-making.
• Integrating PK-PD modeling early in preclinical stages can improve clinical trial success.
• Optimized dosing strategies can be developed for specific patient populations.